Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab and Metformin in Relapsed PD-L1 Positive SCLC
NCT03994744Phase 2Unknown
- Sponsor
- Hunan Cancer Hospital
- Start
- Aug 2019
- Primary completion
- Aug 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in small cell lung cancer (SCLC), sponsored by Hunan Cancer Hospital. Status: unknown.
02
Drugs
sintilimab
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT03994744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03994744.